Role of Dlg5/lp-dlg, a Membrane-Associated Guanylate Kinase Family Protein, in Epithelial-Mesenchymal Transition in LLc-PK1 Renal Epithelial Cells by Sezaki, Takuhito et al.
Role of Dlg5/lp-dlg, a Membrane-Associated Guanylate
Kinase Family Protein, in Epithelial-Mesenchymal
Transition in LLc-PK1 Renal Epithelial Cells
Takuhito Sezaki
1., Kohki Inada
1., Takayuki Sogabe
1, Kumiyo Kakuda
1, Lucia Tomiyama
1,
Yohsuke Matsuno
1, Takafumi Ichikawa
1, Michinori Matsuo
1, Kazumitsu Ueda
1,2, Noriyuki Kioka
1*
1Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Sakyo, Kyoto, Japan, 2Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto
University, Sakyo, Kyoto, Japan
Abstract
Discs large homolog 5 (Dlg5) is a member of the membrane-associated guanylate kinase adaptor family of proteins, some of
which are involved in the regulation of epithelial-to-mesenchymal transition (EMT). Dlg5 has been described as a
susceptibility gene for Crohn’s disease; however, the physiological function of Dlg5 is unknown. We show here that
transforming growth factor-b (TGF-b)-induced EMT suppresses Dlg5 expression in LLc-PK1 cells. Depletion of Dlg5
expression by knockdown promoted the expression of the mesenchymal marker proteins, fibronectin and a-smooth muscle
actin, and suppressed the expression of E-cadherin. In addition, activation of JNK and p38, which are stimulated by TGF-b,
was enhanced by Dlg5 depletion. Furthermore, inhibition of the TGF-b receptor suppressed the effects of Dlg5 depletion.
These observations suggest that Dlg5 is involved in the regulation of TGF-breceptor-dependent signals and EMT.
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Introduction
Discs large homolog 5 (Dlg5)/placenta-dlg(p-dlg)/large type of
p-dlg(lp-dlg)/KIAA0583 (hereafter referred to as Dlg5) is a
member of the membrane-associated guanylate kinase (MAGUK)
adaptor family of proteins, in which some members are involved in
the regulation of EMT [1,2]. The MAGUK family of proteins
shares at least one PDZ (PSD-95, Dlg, ZO-1) domain, an SH3
domain, and a guanylate kinase domain. Dlg5 was initially
proposed to be one of five human homologs of the Drosophila Discs
large (Dlg) protein, a tumor suppressor gene in imaginal discs,
based on similarities in sequence and domain structure [3].
However, recent computational analysis has revealed that Dlg5
does not belong to the DLG MAGUK subfamily defined by
DLG1-4 in humans but rather has its own ortholog in other
animals including Drosophila [4].
Dlg5 has been described as a susceptibility gene for Crohn’s
disease, one of two subphenotypes of inflammatory bowel disease
[5], although the involvement of this gene in this disease is still
controversial [6,7]. Recent reports have shown that polymor-
phisms in Dlg5 are associated with Crohn’s disease in a gender-
and age-specific manner [8,9,10]. To examine whether Dlg5 plays
a role in Crohn’s disease and how Dlg5 affects the disease, the
physiological function of Dlg5 should be clarified. We have
isolated Dlg5 as a binding protein for vinexin, a protein localized
to cell-cell adhesion sites and focal adhesions [11,12]. We have
also shown that Dlg5 associates with b-catenin and localizes to
cell-cell adhesion sites [11]. Others have identified several other
Dlg5 binding proteins [3,13,14]. Although reports have demon-
strated that the Dlg5 gene knockout shows defects in the kidney
and brain, the physiological function of Dlg5 in renal as well as
intestinal epithelial cells remains poorly understood.
Epithelial cells can be converted into mesenchymal cells by a
process called epithelial-to-mesenchymal transition (EMT)
[15,16,17]. Epithelial cells form cell sheets that have strong cell-
cell adhesions mediated by specialized structures, such as tight
junctions, adherens junctions, and desmosomes. Epithelial cells
show limited motile activity and have apical-basolateral polarity.
Mesenchymal cells, in contrast, have higher motile activity, an
elongated fibroblastic morphology, and anterior-posterior polarity.
The process of EMT involves the disruption of tight cell-cell
adhesions, loss of apical-basolateral polarity, and an acquisition of
a higher motile activity, concomitant with a shift in cytoskeletal
dynamics. This process is also associated with dramatic changes in
gene expression, including a loss of junction components, such as
E-cadherin, and an increase in mesenchymal markers, including
fibronectin and a-smooth muscle actin (SMA) [17,18]. Although it
is well established that EMT plays an important role in various
physiological and pathophysiological conditions, including em-
bryogenesis, tumor invasion, and renal fibrosis
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understood.
Here we investigated the role of Dlg5 in the renal epithelial cell
line, LLc-PK1, which exhibits high levels of Dlg5 expression. We
found that transforming growth factor-b (TGF-b)-induced EMT
suppressed the expression of Dlg5 in LLc-PK1 cells. Depletion of
Dlg5 expression by RNAi-mediated knockdown promoted the
expression of the mesenchymal marker proteins, fibronectin and
SMA, and suppressed the expression of E-cadherin. Re-expression
of Dlg5 attenuated the induction of SMA expression observed in
Dlg5-depleted cells. Moreover, the induction of SMA expression
by Dlg5 depletion was dependent on TGF-b receptor (TbR)-
mediated signaling. These observations suggest that Dlg5 plays a
role in TGF-b receptor-dependent signaling and EMT in LLc-
PK1 cells.
Methods
Antibodies and Reagents
SP600125 and SB203580 were from Tocris Bioscience (Ellis-
ville, MO). ALK5 inhibitor II was from WAKO Pure Chemical
Industries (Osaka, Japan). TGF-b was obtained from R&D
Systems (Minneapolis, MN). EZ-Link
TM Sulfo-NHS-Biotin and
monomeric-avidin conjugated agarose beads were purchased from
Pierce.
The following antibodies were used in this study: anti-
fibronectin (BD Transduction), anti-E-cadherin (BD Transduc-
tion), anti-b-tubulin (Sigma), anti-GFP (Santa Cruz Biotechnolo-
gy), anti-SMA (Sigma), anti-b-catenin (BD Transduction), anti-p-
Smad2 (Cell Signaling Technology), anti-Smad2 (Cell Signaling
Technology), anti-p-JNK (Cell Signaling Technology), anti-JNK1
(Santa Cruz Biotechnology), anti-p38 (Cell Signaling Technology),
anti-p-p38 (Cell Signaling Technology), and anti-vinculin (Sigma).
The anti-Dlg5 and anti-vinexin antibodies were described
previously [11,23].
Cell culture, plasmids, and transfection
Porcine renal epithelial LLc-PK1 cells (American Type Culture
Collection) and PC3 cells (American Type Culture Collection)
were maintained in Medium199 and RPMI1640 containing 10%
fetal bovine serum, respectively. Experiments were performed on
collagen IV coated dishes unless otherwise indicated. In some
experiments, cells were incubated with TGF-b (4 ng/ml) for the
indicated number of hours. FLAG-tagged Dlg5 has been described
previously [11]. For lentivirus-mediated transfection, GFP-tagged
Dlg5 was subcloned into pCDH-EF1-IRES-blasticidin (System
Biosciences) and Dlg5 shRNA plasmid was purchased from Open
Biosystems. Plasmids encoding the Smad7 and TGF-b receptors
were gifts from Dr. S. Aota (RIKEN, Japan). Dominant negative
mutant of JNK [24] and p38 [25] were kind gifts from Dr. S.
Tamura (Tohoku University, Japan) and Dr. Y. Gotoh (University
of Tokyo, Japan), respectively. Transfection of plasmid DNA was
performed using Lipofectamine LTX (Invitrogen) or FuGENE
HD (Roche Diagnostics K.) according to the manufacturer’s
instructions.
RNA interference (RNAi)
The stealth siRNAs for Dlg5/lp-dlg (siDlg5#1, AAGCUCA-
GAAUAAGCGGAACUUGAU; siDlg5#2, CCAACCUUU-
CUUGUAGCCAGCUGAU) and for b-catenin (UAGAAGCUG-
GUGGAAUGCAAGCUUU) were designed based on the
sequence of the porcine genome or porcine cDNA (FP085540,
NM_214367) and synthesized by Invitrogen. The siRNA for GFP
(GGGCACAAGCUGGAGUACAACUACA), which was used as
a control, and the negative control siRNA3 were from Invitrogen.
The transfection of siRNAs (10 nM) was performed using
LipofectAmine RNAiMax (Invitrogen) as described [26].
mRNA Quantification by Real-time PCR
Real-time PCR was performed as described [27]. Briefly, total
RNA was isolated using an RNeasy Mini Kit (Qiagen). cDNA was
generated from 100 ng of each total RNA sample using the
Superscript III First-Strand Synthesis system (Invitrogen). The
resulting cDNA samples were subjected to quantitative real-time
PCR reactions using the StepOne Real-Time PCR System
(Applied Biosystems). Independent PCRs were performed using
the same cDNA for both the gene of interest (Dlg5, E-cadherin, and
snail) and GAPDH, using the Fast SYBR Green Master Mix
(Applied Biosystems) with the following gene-specific primer pairs:
Dlg5 forward, 59-CTTCAAGCAACTTGCAGTTCAAG-39, and
reverse, 59-TCAGAACCCACGACAGATCGT-39; E-cadherin for-
ward, 59-CTCTGGCCGAAGCAGGATT-39, and reverse, 59-
GCAAGGATGCCTCCCAGAAT-39; snail forward, 59- CTC-
GCAAGGCCTTCAACTG-39, and reverse, 59-GAGAGCACC-
CAGGCTGACA-39; GAPDH forward, 59-CCTCCTGTACCAC-
CAACTGCTT-39, and reverse, 59-GCCGAAGTTGTCATG-
GATGA-39. The primers were designed using Primer Express
software (Applied Biosystems). A dissociation curve was generated
at the end of each PCR cycle to verify that a single product was
amplified. Each RNA sample was amplified in duplicate. The
results were normalized to GAPDH mRNA as an internal control.
The relative level of each mRNA was calculated by the
‘‘comparative CT method’’ in StepOne v1.0 software (Applied
Biosystems). The values represent the mean 6 S.D. from three
independent experiments.
Immunofluorescence microscopy
Cells were cultured on glass coverslips or, in some cases, on
collagen IV-coated coverslips. The cells were fixed with methanol
for 15 minutes at 220uC for Dlg5 immunostaining or with 4%
paraformaldehyde containing 5% sucrose for 30 minutes at room
temperature and permeabilized in 0.2% TritonX-100/PBS for
5 minutes. They were then blocked with 10% goat serum/PBS (+)
for 1 hour and incubated with primary antibodies for 1 hour. The
cells were stained with Alexa Fluor-labeled secondary antibody
(Molecular Probes) for 45 minutes. Fluorescence images were
taken with a BX51 microscope (Olympus) equipped with an
ORCA-ER CCD camera (Hamamatsu Photonics, Hamamatsu,
Japan), a PASCAL confocal microscopy system (Carl Zeiss Co.,
Ltd), or a LSM700 confocal microscopy system (Carl Zeiss Co.,
Ltd).
Detection of cell surface proteins
LLc-PK1 cells transfected with control or Dlg5 siRNA were
washed with ice-cold PBS and incubated with 0.5 mg/ml sulfo-
NHS-biotin (Pierce) in PBS for 30 min on ice in the dark. The cells
were washed with PBS to remove unbound sulfo-NHS-biotin and
lysed in RIPA buffer containing protease- and phosphatase-
inhibitors as previously described [28]. Equal amounts of protein
were incubated with monomeric-avidin conjugated agarose beads
(Pierce) for 2 hours at 4uC to precipitate the biotinylated proteins.
The precipitated proteins were subjected to SDS-PAGE and
detected by immunoblotting.
Statistical analysis
Statistical analysis was performed using Student’s paired t-test.
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TGF-b disrupts the epithelial cell morphology of LLc-PK1
cells and decreases Dlg5 expression
Some members of the MAGUK family of proteins, including
Dlg1 and ZO-1, are involved in EMT [1,2]. Thus, we first
examined whether TGF-b-induced EMT affects Dlg5 expression.
We used renal proximal tubular epithelial LLc-PK1 cells because
Dlg5 is highly expressed in these cells as well as in kidney of
humans and mice [11,13]. LLc-PK1 cells were incubated with
TGF-b for three days. Treatment with TGF-b changed the cell
morphology from a typical epithelial cell-like to an elongated
fibroblast like-morphology (Fig. 1A). Compared with control cells,
the expression of E-cadherin (an epithelial marker) was lower, and
the expression of SMA and fibronectin (mesenchymal markers)
was higher in TGF-b-treated cells (Fig. 1B), indicating that TGF-b
stimulation induced EMT in LLc-PK1 cells as previously reported
[29,30]. As shown in Fig. 1B, TGF-b-induced EMT downregu-
lated the expression of Dlg5 in LLc-PK1 cells. Real-time PCR
analysis showed that Dlg5 mRNA was decreased in TGF-b-
treated cells (Fig. S1A). Interestingly, the expression of both
vinexin a and b, which associate and colocalize with Dlg5 at cell-
cell adhesion sites, was also decreased in TGF-b treated cells,
although the expression of vinculin was not affected (Fig. S1B).
Although N-cadherin expression is increased by EMT in other
cells [17,18], a significant increase in N-cadherin expression was
not detected in LLc-PK1 cells under the conditions examined
(data not shown). Immunofluorescence analysis also showed that
Dlg5 expression was downregulated in TGF-b-treated cells
(Fig. 1C). Both Dlg5 and E-cadherin localized to cell-cell adhesion
sites and co-localized in control cells, as we have previously
reported [11]. TGF-b stimulation reduced the signals of Dlg5 and
E-cadherin at adhesion sites. These observations suggest that Dlg5
may be involved in TGF-b-induced EMT or maintenance of
epithelial cell morphology in LLc-PK1 cells.
Decreasing Dlg5 expression disrupts epithelial cell
morphology and induces the expression of mesenchymal
marker proteins
To investigate a potential role of Dlg5 in EMT, siRNA specific
for Dlg5 was transfected into LLc-PK1 cells. Immunoblotting
showed that cells transfected with the Dlg5-specific siRNA
(siDlg5#1) exhibited reduced levels of Dlg5 by 80% compared
to cells transfected with control siRNA (Fig. 2A). We found that
the depletion of Dlg5 expression by knockdown disrupted the
epithelial cell morphology of LLc-PK1 cells and that the cells
developed an elongated fibroblast-like morphology (Fig. 2B).
Furthermore, E-cadherin expression was downregulated, and the
expression of SMA and fibronectin was upregulated in Dlg5-
depleted cells (Fig. 2A). We also confirmed the decrease in E-
cadherin protein expression by immunofluorescence analysis
(Fig. 2C) and in E-cadherin mRNA levels by real-time PCR
(Fig. S2). To further investigate the effect of Dlg5 depletion,
another siRNA for Dlg5 (siDlg5#2) was transfected into LLc-PK1
cells. The reduced expression of Dlg5 was confirmed by
immunoblotting. The siDlg5#2-induced reduction of Dlg5
expression also led to a decrease in E-cadherin expression and
an increase in fibronectin and SMA expression (Fig. S3). However,
the increase in SMA was smaller than that observed in siDlg5#1-
transfected cells, possibly due to the cytotoxic effects of siDlg5#2.
Because Dlg5 knockdown had the most prominent effect on SMA
expression, we focused on SMA expression in the following
experiments.
To corroborate the effect of Dlg5 depletion, we tested whether
re-expression of Dlg5 suppresses the induction of SMA in Dlg5-
depleted cells. Endogenously expressed porcine Dlg5 was reduced
by the transfection of siRNA specific for porcine Dlg5. A plasmid
encoding FLAG-tagged human Dlg5 or a control plasmid was
then co-transfected with a GFP-expressing plasmid into LLc-PK1
cells. SMA expression in GFP-expressing cells was examined by
immunofluorescence analysis. As shown in Fig. 2D, SMA
expression was detected in only a small number of control cells
(,20%). In contrast, 70% of Dlg5-depleted cells expressed SMA.
As expected, re-introduction of human Dlg5 into Dlg5-depleted
cells decreased the number of SMA-expressing cells. Western blot
analysis was also performed to investigate the effect of Dlg5 re-
expression. Re-expression of FLAG-Dlg5 in Dgl5-depleted cells
suppressed SMA expression (Fig. 2E). These results suggest that
Dlg5 is crucial for the regulation of EMT or the maintenance of
the epithelial features of LLc-PK1 cells.
To investigate whether Dlg5 function in the regulation of EMT
is cell-type specific, we used PC3 cells, which are derived from
human prostate cancer. Prostate is one of tissues expressing high
levels of Dlg5 ([3] and unpublished results). Dlg5 expression in
PC3 cells was knocked down by transfection of an shRNA plasmid
for human Dlg5. Expression of Dlg5 was reduced by 90% in the
shRNA-transfected cells. We found that E-cadherin expression
was decreased, but fibronectin expression was increased in these
cells (Fig. S4). This result suggests that the function of Dlg5 in
Figure 1. TGF-b-mediated EMT decreases Dlg5 expression. A:
LLc-PK1 cells were incubated with 4 ng/ml of TGF-b for three days.
Images were taken using phase contrast microscopy. TGF-b treatment
induced morphological changes of LLc-PK1 cells. B: Three days after
incubation with TGF-b, cells were lysed and immunoblotted using the
indicated antibodies, which include an antibody for the epithelial
marker E-cadherin, antibodies for the mesenchymal markers SMA and
fibronectin, and antibodies for Dlg5 and b-catenin. As a loading control,
vinculin expression was detected. C: LLc-PK1 cells were incubated with
4 ng/ml of TGF-b for three days. The cells were immunostained with
anti-Dlg5 or anti-E-cadherin antibody. The scale bar indicates 10 mm.
TGF-b treatment induced EMT and decreased Dlg5 expression. The
results are representative of at least three independent experiments.
doi:10.1371/journal.pone.0035519.g001
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observed in other cell types.
We next examined whether Dlg5 overexpression inhibits EMT
induced by TGF-b. LLc-PK1 cells overexpressing GFP-tagged
Dlg5 were established by using lentivirus-mediated transfection. As
shown in Fig. 3, Dlg5 overexpression suppressed TGF-b-induced
fibronectin and SMA expression and slightly rescued E-cadherin
expression. Together, these results suggest that Dlg5 is involved in
EMT induced by TGF-b
Dlg5 depletion promotes JNK and p38 activation
We next examined which molecules mediate the effect of Dlg5
depletion on EMT. b-catenin is one candidate because it enhances
EMT in several cell systems [15,17] and associates with Dlg5
Figure 2. Dlg5 depletion disrupts epithelial cell morphology and induces the expression of mesenchymal marker proteins. A: LLc-
PK1 cells were transfected with Dlg5 siRNA (siDlg5#1: KD) or control siRNA and then incubated with 4 ng/ml of TGF-b for three days. The cells were
lysed and immunoblotted using the indicated antibodies. Expression of b-tubulin was examined as a loading control. The upper band observed in
immunoblotting with anti-Dlg5 is the larger variant of Dlg5. B: Cells were treated as in A and incubated for 60 hours. The cells were then
photographed using phase contrast microscopy to examine cell morphology. C: Cells were transfected with Dlg5 siRNA or control siRNA and then
immunostained using anti-Dlg5 or anti-E-cadherin antibodies. The asterisks indicate the cells that were transfected with Dlg5 siRNA. The scale bar
indicates 10 mm. D: LLc-PK1 cells were transfected with Dlg5 siRNA or control siRNA and incubated for 24 hours. A GFP expression plasmid was then
transfected into the cells with FLAG-Dlg5 or control plasmids. After incubation for two days, the cells were immunostained using an anti-SMA
antibody. Fifty GFP-expressing cells were randomly selected, and the fluorescent intensity of SMA staining was examined. The graph shows the ratio
of cells with higher SMA expression than background. E: LLc-PK1 cells were transfected with FLAG-Dlg5 or control plasmid and incubated for six
hours. The cells were further transfected with Dlg5 siRNA or control siRNA. After two days of incubation, the cells were lysed and immunoblotted
using the indicated antibodies. Arrows indicate endogenously expressed Dlg5, and an arrow head indicates FLAG-Dlg5. Dlg5 depletion induced the
expression of mesenchymal marker proteins, and the re-expression of Dlg5 suppressed it.
doi:10.1371/journal.pone.0035519.g002
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catenin expression or the subcellular distribution of b-catenin
between the nucleus and the cytosol (data not shown). To further
investigate the role of b-catenin in EMT induced by Dlg5
depletion, both Dlg5 and b-catenin were knocked down
simultaneously in LLc-PK1 cells (Fig. S5). The expression of b-
catenin was successfully reduced by 80% in the siRNA-transfected
cells. However, knockdown of b-catenin did not suppress the
expression of SMA or fibronectin induced by Dlg5 depletion. b-
catenin knockdown also did not rescue E-cadherin expression,
although E-cadherin expression was reduced regardless of TGF-b
stimulation or Dlg5 depletion, possibly due to the destabilization of
E-cadherin without b-catenin. Together, these observations
suggest that molecules other than b-catenin are involved in the
Dlg5-mediated regulation of EMT.
We next investigated Snail and Slug expression, EMT-
regulating transcriptional factors. Although Western blotting using
several commercially available antibodies did not detect either
Snail or Slug protein expression (data not shown), real-time PCR
analysis revealed a slight increase in the expression of Snail mRNA
after Dlg5 depletion (Fig. S6). The increase was much less than
that observed in TGF-b treated cells. Slug mRNA was hardly
detected both in Dlg5-depleted and TGF-b treated cells. Together,
these results suggest that Snail may have a role in the Dlg5-
mediated regulation of EMT.
Next, we focused on TGF-b-induced signaling. TGF-b
stimulation increases the phosphorylation of regulatory Smads,
such as Smad2 and Smad3. Once phosphorylated, these Smads
form a complex with Smad4, which leads to their translocation
into the nucleus and the transcriptional activation of various target
genes. In addition, TGF-b activates the non-Smad pathway, which
includes MAP kinase signals, such as JNK and p38 [31,32]. Both
Smad and non-Smad pathways stimulate EMT. In LLc-PK1 cells,
TGF-b stimulation increased the phosphorylation of Smad2 as
well as p38 and JNK MAP kinases (Fig. 4A). However, Smad3
phosphorylation was not increased in LLc-PK1 cells (data not
shown). Thus, we investigated the effects of Dlg5 depletion on
Smad and non-Smad signals (Fig. 4B–E). Two days after
transfection of Dlg5 siRNA (siDlg5#1), a moderate but statistically
significant (2-fold) increase in JNK activation was observed even
without TGF-b stimulation (P,0.05). Dlg5-depleted cells also
showed a 2.5-fold increase in p38 activation (P,0.05). Because
these increases were detected two days after transfection of siRNA,
these activations seem to be sustained. In contrast, TGF-b
stimulation induces strong but only transient activation of these
signals. Thus, moderate activation of JNK and p38 induced by
Dlg5 knockdown seems to play an important role. Enhanced
activation of JNK and p38 were also observed in siDlg5#2-
transfected cells (data not shown). Dlg5 depletion slightly
enhanced JNK and p38 activation even in TGF-b stimulated
cells (data not shown), possibly because strong transient activation
of JNK and p38 induced by TGF-b obscures the enhancement
induced by Dlg5 depletion. In contrast, phosphorylation of Smad2
and Smad3 was not affected by Dlg5 depletion, either with
(Fig. 4D, E) or without TGF-b stimulation (data not shown). These
results suggest that Dlg5 attenuates the activation of JNK and p38
MAP kinases in LLc-PK1 cells.
Inhibition of MAP kinases suppresses Dlg5 depletion-
mediated EMT
To investigate whether these MAP kinase signals are involved in
Dlg5 depletion-induced EMT, dominant-negative mutants of
MAP kinases were used. LLc-PK1 cells were transfected with a
dominant negative JNK mutant, followed by transfection of
control or Dlg5 siRNA. As shown in Fig. 5A, expression of the
dominant-negative JNK mutant clearly suppressed the increases in
fibronectin and SMA expression induced by Dlg5 depletion and
slightly rescued E-cadherin expression. Considering the transfec-
tion efficiency of the plasmid (,40%), dominant-negative JNK
suppressed most increases in fibronectin and SMA expression and
moderately rescued E-cadherin. Relatively small effects on E-
cadherin expression may indicate that other signals are also
involved in E-cadherin expression. Inhibition of JNK activity by
an inhibitor (SP600125) also suppressed the increase in fibronectin
expression induced by Dlg5 depletion (data not shown). Together,
these observations indicate the importance of JNK activation in
Dlg5 depletion-induced EMT in LLc-PK1 cells.
We also examined the effect of inhibiting p38 kinase. LLc-PK1
cells were first transfected with a dominant-negative p38 mutant
followed by the transfection of siRNA. Expression of the
dominant-negative p38 mutant exhibited effects on fibronectin,
SMA, and E-cadherin expression as the expression of the
dominant-negative JNK mutant (Fig. 5B). Inhibition of p38 kinase
activity by an inhibitor (SB203580) also suppressed the increase in
fibronectin expression induced by Dlg5 depletion (data not
shown). All together, these results suggest that both JNK and
p38 kinase signaling induced by Dlg5 depletion are involved in the
regulation of EMT.
EMT induced by Dlg5 depletion involves TGF-b receptor-
mediated signaling
TGF-b stimulation transmits signals via two serine-threonine
kinase receptors, type I (TbRI) and type II (TbRII). Binding of
TGF-b to TbRII induces the formation of a complex between
TbRII and TbRI, leading to the activation of downstream signals
[33]. The observations that Dlg5 depletion enhanced JNK and
p38 activation, both of which are stimulated by TGF-b, and that
overexpression of Dlg5 inhibited TGF-b induced-EMT raise the
possibility that Dlg5-mediated regulation involves TGF-b recep-
tor-dependent signaling. TGF-b receptor-mediated signaling can
be stimulated by an autocrine mechanism. However, no increase
in the secretion of latent or activated TGF-b into the medium was
detected by ELISA assay (data not shown).
Figure 3. Overexpression of Dlg5 attenuates the TGF-b-
mediated increase in the expression of mesenchymal marker
proteins. LLc-PK1 cells stably expressing GFP or GFP-tagged Dlg5 were
treated with or without 4 ng/ml TGF-b. After two days of incubation,
cells were lysed and protein expression was detected by immunoblot-
ting using the indicated antibodies. Exogenously expressed Dlg5
suppressed the increase in SMA and fibronectin expression.
doi:10.1371/journal.pone.0035519.g003
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induced by Dlg5-depletion, a chemical inhibitor of the TGF-b
receptor, ALK5 inhibitor II, was employed. LLc-PK1 cells
transfected with Dlg5 siRNA or stimulated with TGF-b were
treated with ALK5 inhibitor II. Inhibition of the TGF-b receptor
by ALK5 inhibitor II almost completely suppressed the increase in
fibronectin and SMA expression observed in Dlg5-depleted cells
and in TGF-b-stimulated cells (Fig. 6A). ALK5 inhibitor II also
rescued E-cadherin expression in Dlg5-depleted cells. The partial
rescue of E-cadherin expression may indicate that other signals
also contribute to the decrease in E-cadherin expression induced
by Dlg5 depletion. Together, these results suggest that TGF-b
receptor-mediated signaling is involved in EMT induced by Dlg5
depletion.
Smad7 is a well-known physiological inhibitor of TGF-b
receptor signaling by promoting the degradation of the TGF-b
receptor and by inhibiting the phosphorylation of Smad2/3
[34,35,36]. When LLc-PK1 cells were transfected with a plasmid
expressing Smad7, the TGF-b-induced increase in SMA and
fibronectin expression was suppressed as expected (Fig. 6B, lanes 2
and 4). Exogenous expression of Smad7 also suppressed the
increases in fibronectin and SMA expression observed in Dlg5-
depleted LLc-PK1 cells (lanes 6 and 8). Together, these results
using chemical and physiological inhibitors indicate a role of Dlg5
in TGF-b receptor-mediated signaling, which is subsequently
involved in the regulation of EMT.
Discussion
Dlg5 is a member of the MAGUK adaptor family of proteins
that localizes to cell-cell adhesion sites. Dlg5 has been reported to
be one of the susceptibility genes for Crohn’s disease [5,37].
However, the physiological function of Dlg5 in cells is poorly
Figure 4. Dlg5 depletion promotes JNK and p38 activation. A: LLc-PK1 cells were stimulated with 4 ng/ml TGF-b and incubated for the
indicated periods. Cells were then lysed and immunoblotted using the indicated antibodies. B, C, D, E: LLc-PK1 cells were transfected with Dlg5
siRNA (KD) or control siRNA and incubated for two days. Cell lysates were then immunoblotted using the indicated antibodies, and the results were
quantitated. The values represent the mean 6 S.E. from at least three independent experiments. Dlg5 depletion promoted JNK and p38 activation
but not Smad2/3 activation.
doi:10.1371/journal.pone.0035519.g004
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35519understood. Here, we show that Dlg5 depletion changes the
epithelial cell morphology of LLc-PK1 cells to an elongated
fibroblast-like morphology. Concomitantly, Dlg5 depletion result-
ed in a decrease in E-cadherin expression and an increase in the
expression of the mesenchymal markers, SMA and fibronectin.
Immunostaining analysis further confirmed the disappearance of
E-cadherin from cell-cell adhesion sites and the disruption of
adherens junctions, suggesting a critical role of Dlg5 in the
regulation of the EMT and the maintenance of the integrity of
epithelial cells.
Dlg5 knockout (2/2) mice have penetrant hydrocephalus and
kidney cysts [13]. Loss of apical-basolateral polarity in epithelial
cells of the collecting ducts has been proposed to be a causal factor
in kidney cysts. Because apical-basolateral polarity requires proper
cell-cell adhesions and epithelial cell morphology, our finding that
decreased Dlg5 expression disrupts cell-cell adhesions and induces
EMT in renal epithelial LLc-PK1 cells may explain the
mechanism behind the loss of apical-basolateral polarity in renal
epithelial cells in Dlg5 (2/2) mice, although LLc-PK1 cells are
derived from renal proximal tubules but not from collecting ducts.
The high level of Dlg5 expression observed in human proximal
tubule epithelial cells by immunohistochemistry suggests a
significant role of Dlg5 in these cells (unpublished data). It is of
interest that cysts found in the kidneys of Dlg5 knockout mice have
a fibrous surface [13], because fibroblasts derived from tubular
epithelial cells via EMT are a major source for the secretion and
deposition of excess extracellular matrix in renal fibrosis [38].
Together, these observations suggest a pivotal role of Dlg5 in
regulating EMT in renal epithelial cells.
TGF-b receptor signaling has a variety of functions, including
the induction of growth arrest, cell death, and cell migration, in
addition to the regulation of EMT. Tumor metastasis also involves
the aberrant activation of TGF-b receptor signaling. We show that
TGF-b receptor signaling mediates EMT induced by Dlg5
depletion. First, Dlg5 depletion activated JNK and p38 MAP
kinases, which are both activated by TGF-b. Inhibition of these
kinases rescued the expression of E-cadherin and suppressed the
increases in SMA and fibronectin expression. Secondly, EMT
induced by Dlg5 depletion was inhibited by either pharmacolog-
ical or physiological inhibitors of the TGF-b receptor. A recent
study [39] showing that Dlg5 inhibits cell migration and the
expression of fibronectin and PAI-1, both of which can be
regulated by TGF-b, in mammary epithelial cells also supports our
findings. Interestingly, expression of Dlg5 in pancreatic cancers
correlates with metastasis to the lymph nodes [40]. Reduction of
Dlg5 expression significantly inhibited the proliferation of
pancreatic cancer cell lines [41]. Although TGF-b signaling was
not examined in these studies, our finding that Dlg5 can regulate
TGF-b signaling is consistent with these reports. Furthermore,
inflammatory bowel diseases, including Crohn’s disease, involve
dysfunction of TGF-b signaling [42,43,44,45]. Thus, Dlg5 may
also affect the pathology of Crohn’s disease via regulation of TGF-
b signaling. Future studies are necessary to examine this
possibility.
Here, we demonstrate that Dlg5 depletion results in a decrease
in E-cadherin protein and mRNA expression in LLc-PK1 cells.
This decrease is dependent on TGF-b receptor signaling. In
contrast, delivery of N-cadherin to the plasma membrane has been
reported to be impaired in Dlg5 (2/2) fibroblasts, leading to a
decrease in cell-surface but not total expression of N-cadherin
[13]. The association of Dlg5 with b-catenin and the t-SNARE
complex has been suggested to be involved in its delivery to the cell
surface [13]. In LLc-PK1 cells, however, the ratio of cell surface to
Figure 5. Dominant-negative mutants of JNK and p38 suppress
the expression of mesenchymal marker proteins in Dlg5-
depleted cells. A: Six hours after transfection of a dominant-negative
JNK mutant or a control plasmid into LLc-PK1 cells, the cells were
further transfected with control or Dlg5 siRNA. After incubation for two
days, expression of the indicated proteins was investigated by
immunoblotting. B: Dominant-negative p38 mutant or a control
plasmid was transfected into LLc-PK1 cells and treated and analyzed
as in A. Expression of b-tubulin was detected as a loading control. The
results are representative of at least three independent experiments.
The expression levels of dominant-negative mutants were affected by
Dlg5 knockdown by an unknown mechanism. Dominant-negative
mutants of JNK and p38 suppressed the expression of fibronectin and
SMA.
doi:10.1371/journal.pone.0035519.g005
Figure 6. Inhibition of the TGF-b receptor suppresses the
expression of mesenchymal marker proteins in Dlg5-depleted
cells. A: LLc-PK1 cells were transfected with Dlg5 siRNA (KD) or control
siRNA and stimulated with or without 4 ng/ml TGF-b. Two days after
the addition of 2 mM ALK5 inhibitor II (TGF-b receptor inhibitor), cells
were lysed and immunoblotted using the indicated antibodies. B: LLc-
PK1 cells were transfected with a Smad7 expression plasmid or control
plasmid and incubated for six hours. The cells were then treated with or
without TGF-b (left panel) or transfected with Dlg5 siRNA or control
siRNA (right panel). Two days after further incubation, cells were lysed
and the expression of the indicated proteins was investigated by
immunoblotting. Expression of b-tubulin was detected as a loading
control. The results are representative of at least three independent
experiments. Both pharmacological and physiological inhibition of TGF-
b receptor suppressed the expression of SMA and fibronectin induced
in Dlg5-depleted cells.
doi:10.1371/journal.pone.0035519.g006
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Dlg5 depletion (data not shown). This observation is consistent
with that observed in MCF10A cells [39]. Furthermore,
knockdown of b-catenin expression did not affect the EMT
induced by Dlg5 depletion. Therefore, these observations suggest
that different mechanisms are used to regulate the cell surface
expression of cadherins in fibroblasts and in LLc-PK1 or MCF10A
epithelial cells.
TGF-b triggers Smad signaling pathways and non-Smad
MAPK signals [32,46]. Our study showed that Dlg5 depletion
activated non-Smad signals, JNK and p38, but not Smad2
phosphorylation. Dlg5 depletion also increased mRNA expression
of Snail, an important regulator of EMT. JNK and p38 as well as
Smad signals induce the expression of Snail in renal epithelial cells
and other cell types [47,48,49,50]. Thus, Snail may mediate the
effect of p38 and JNK on EMT induced by Dlg5 depletion.
TRAF6 has recently been reported to associate with TbR and
induce Smad-independent activation of p38 and JNK but not
Smad signaling. TAK1 also interacts with TbR and stimulates p38
and JNK activation [51,52,53]. The distribution of TbR to lipid
rafts and non-rafts also plays a role in Smad and non-Smad
signaling [54]. We examined TAK1 activation and the distribution
of TbR to lipid rafts, but we have not yet obtained any evidence
suggesting that Dlg5 affects these events, although interaction
between exogenously expressed Dlg5 and TbRI was observed
(unpublished data). Dlg5 may affect another mechanism that
regulates non-Smad signaling but not Smad signaling.
In summary, we found that TGF-b-induced EMT suppresses
Dlg5 expression in LLc-PK1 cells. Depletion of Dlg5 expression by
knockdown promoted the expression of the mesenchymal marker
proteins, fibronectin and SMA, and suppressed the expression of
E-cadherin. JNK and p38 activation, which are stimulated by
TGF-b, were enhanced by Dlg5 depletion. Furthermore, induc-
tion of fibronectin and SMA expression by Dlg5 depletion was
dependent on TGF-b receptor-mediated signaling. These obser-
vations suggest that Dlg5 is involved in the regulation of TGF-b
receptor-dependent signaling and EMT in LLc-PK1 cells.
Supporting Information
Figure S1 The expression of Dlg5 and vinexin a/b after
TGF-b stimulation. A: LLc-PK1 cells were incubated with
4 ng/ml of TGF-b for two days. Total RNA was isolated from the
cells and Dlg5 mRNA was quantitated by real-time PCR. The
values represent the mean 6 S.E. of relative mRNA amounts from
three independent experiments. B: LLc-PK1 cells were incubated
with 4 ng/ml of TGF-b for three days. The expression of vinexin
a and b was determined by immunoblotting. As a loading control,
vinculin expression was detected.
(TIF)
Figure S2 E-cadherin mRNA in Dlg5-knockdown cells.
Control siRNA (GFP siRNA or control siRNA1 (unrelated)) or
Dlg5 siRNA (#1o r#2) was transfected into LLc-PK1 cells. Two
days after transfection, total RNA was isolated from the cells and
E-cadherin mRNA was quantitated by real-time PCR. The values
represent the mean 6 S.E. of relative mRNA amounts from three
independent experiments.
(TIF)
Figure S3 Effect of siDlg5#2 on expression of SMA and
fibronectin. LLc-PK1 cells were treated with 4 ng/ml TGF-b or
transfected with control siRNA or Dlg5 siRNA (#1, #2) followed
by incubation for three days. Cells were lysed and protein
expression detected by immunoblotting using the indicated
antibodies. b-tubulin expression was examined as a loading
control. A line was inserted to indicate a vertically spliced lane;
however, all samples were loaded on the same gel.
(TIF)
Figure S4 Effect of depletion of Dlg5 expression in PC3
cells. shRNA plasmid for Dlg5 or control plasmid were
introduced into PC3 cells using lentivirus. Transfected cells were
selected by the incubation with 1.0 mg/ml puromycin. Lysates
were prepared from cells stably transfected with shRNA for Dlg5
or control plasmid. The cell lysates were immunoblotted using the
indicated antibodies. b-tubulin expression was detected as a
loading control. Depletion of Dlg5 expression in PC3 cells induced
the increase in fibronectin expression and the decrease in E-
cadherin expression.
(TIF)
Figure S5 Effect of b-catenin knockdown. Dlg5 siRNA and
b-catenin siRNA were transfected into LLc-PK1 cells with or
without stimulation with 4 ng/ml TGF-b. After three days of
incubation, cells were lysed and protein expression detected by
immunoblotting using the indicated antibodies.
(TIF)
Figure S6 Snail mRNA in TGF-b treated and Dlg5-
knockdown cells. LLc-PK1 cells were transfected with control
siRNA or Dlg5 siRNA#1 (A) or treated with 4 ng/ml TGF-b (B).
After two days of incubation, total RNA was isolated from the cells
and Snail mRNA was quantitated by real-time PCR. The values
represent the mean 6 S.E. of relative mRNA amounts from three
independent experiments.
(TIF)
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